Skip to main content
Premium Trial:

Request an Annual Quote

GenomeDx Biosciences Closes Series A Funding Round

NEW YORK (GenomeWeb News) – Vancouver-based molecular diagnostics technologies developer GenomeDx Biosciences has closed an undisclosed amount of Series A round of financing.

The company said on Monday that the funding was led by Baird Venture Partners and Aeris Capital AG. The round includes investments from CD Ventures and other individual investors.

Founded in 2007 by Tim Triche, a member of BVP's advisory board, GenomeDx develops and sells molecular diagnostic tests and clinical support tools for personalized medicine applications in clinical cancer care.

The Scan

Omicron's Emergence

The World Health Organization has called Omicron a SARS-CoV-2 "variant of concern," the Los Angeles Times writes.

Not as Much

Merck's pill to treat COVID-19 reduces the risk of hospitalization and death among COVID-19 patients by less than previously reported, the New York Times says.

Bats That Hang Together

Discover magazine writes that researchers have found a social microbiome among vampire bats.

PLOS Papers on CEWAS, Simian Varicella Virus Transcriptome, Dermatomyositis Markers

In PLOS this week: multi-omic approach to home in on genetic risk variants, transcriptomic analysis of the simian varicella virus, and more.